Impaired axonal transport may play an early, pivotal role in a variety of neurodegenerative disorders including Parkinson's disease (PD). When axon transport is disrupted, trophic support is lost, synaptic vesicles and transmitters are depleted, biological materials accumulate, degeneration occurs and ultimately the neuron dies. As a pathological precursor, impaired axonal transport is particularly compelling in PD because disruption of synaptic function and the presence of axon pathology is an early, common feature. Research in this area is limited, however, by the lack of tools to selectively image and target CNS axons. Towards this end, we have modified a compartmented system designed for peripheral cultures such that CNS neurons can be grown with axons segregated to one side of a barrier. When used with GFP-labeled dopaminergic neurons derived from genetically engineered mice, dopaminergic axons can be examined using live cell, real time imaging. The goal of the current application is to utilize our unique ability to monitor axonal transport in CNS dopaminergic neurons to test a nested set of hypotheses that PD-associated neurotoxins and genetic mutations trigger early changes in axon transport that contribute to the loss of synaptic function and cell death. Specifically, we hypothesize that the PD-mimetic MPP+ affects mitochondrial and vesicular axon trafficking leading to the loss of synaptic function, that this occurs via mitochondrial-dependent and independent processes, and that mutations in the PD-linked gene LRRK2 will affect similar transport processes of organelles and vesicles as MPP+. Optical, molecular and cellular techniques will be used to determine axonal transport and signaling pathways associated with mitochondrial and vesicular movement in dopaminergic axons. These experiments will provide insights impossible to obtain from standard culture or animal models. Taken together, the proposed studies will determine whether environmentally or genetically induced axonal injury plays a central role in the death of dopaminergic neurons. If so, novel therapies can be targeted to the elucidated control points in order to stop or slow disease progression.

Public Health Relevance

Environmental or genetic factors associated with Parkinson's disease may affect fundamental mechanisms underlying the way in which a neuron sends biological materials down an axon. This may compromise the ability of neurons to communicate with each other, lead to the accumulation of proteins and organelles, and ultimately cause the axon and subsequently the neuron to degenerate. Identifying and characterizing how axonal injury occurs in Parkinson's disease has enormous potential for the discovery of novel therapies that can be targeted to the elucidated control points in order to stop or slow disease progression.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Clinical Neuroplasticity and Neurotransmitters Study Section (CNNT)
Program Officer
Sieber, Beth-Anne
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Bernstein, Alison I; O'Malley, Karen L (2013) MPP+-induces PUMA- and p53-dependent, but ATF3-independent cell death. Toxicol Lett 219:93-8
Antenor-Dorsey, Jo Ann V; O'Malley, Karen L (2012) WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity. Mol Neurodegener 7:5
Kim-Han, Jeong Sook; Antenor-Dorsey, Jo Ann; O'Malley, Karen L (2011) The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons. J Neurosci 31:7212-21
Bernstein, Alison I; Garrison, Sean P; Zambetti, Gerard P et al. (2011) 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Mol Neurodegener 6:2
Kim-Han, Jeong Sook; O'Malley, Karen L (2007) Cell stress induced by the parkinsonian mimetic, 6-hydroxydopamine, is concurrent with oxidation of the chaperone, ERp57, and aggresome formation. Antioxid Redox Signal 9:2255-64
Hasbani, Daphne M; O'Malley, Karen L (2006) Wld(S) mice are protected against the Parkinsonian mimetic MPTP. Exp Neurol 202:93-9
Holtz, William A; Turetzky, Jay M; Jong, Yuh-Jiin I et al. (2006) Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics. J Neurochem 99:54-69
Holtz, William A; Turetzky, Jay M; O'Malley, Karen L (2005) Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death. Antioxid Redox Signal 7:639-48
Hasbani, Daphne M; Perez, Francisco A; Palmiter, Richard D et al. (2005) Dopamine depletion does not protect against acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in vivo. J Neurosci 25:9428-33
Jensen, Penny J; Alter, Benedict J; O'Malley, Karen L (2003) Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J Neurochem 86:196-209

Showing the most recent 10 out of 13 publications